linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Board Meetings  
Jagsonpal Pharmaceuticals Ltd.
 
Source DateBoard Meeting DateDetails
29 Apr 202506 May 2025 Audited Results & Final Dividend
15 Jan 202522 Jan 2025 Quarterly Results
16 Oct 202423 Oct 2024 Stock Split & Quarterly Results
31 Jul 202407 Aug 2024 Quarterly Results
13 May 202420 May 2024 Final Dividend & Audited Results
25 Jan 202402 Feb 2024 Quarterly Results
26 Oct 202303 Nov 2023 Quarterly Results
25 Jul 202302 Aug 2023 Quarterly Results
15 May 202323 May 2023 Dividend & Audited Results
31 Jan 202308 Feb 2023 Quarterly Results
03 Nov 202209 Nov 2022 Quarterly Results
04 Aug 202209 Aug 2022 Quarterly Results
23 May 202230 May 2022 Audited Results & Quarterly Results
04 May 202213 May 2022 Inter alia, to consider and approve the alteration in AOA and other routine matters.
03 Feb 202211 Feb 2022 Quarterly Results
19 Jan 202227 Jan 2022JAGSONPAL PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2022 ,inter alia, to consider and approve unaudited financial results for the quarter and nine months ended 31.December.2021.
12 Oct 202119 Oct 2021 Quarterly Results & Interim Dividend
04 Aug 202113 Aug 2021 Quarterly Results
23 Jun 202130 Jun 2021 A.G.M. & Dividend & Audited Results
14 May 202125 May 2021 Inter alia, to consider and approve investment in the associate company along with other routine matters.
Page 1 of 5
Prev || Next
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.